Education
About Us
Working with TipRanks
Follow Us
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Comparison Results
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$11.00B
14.47
5.24%
―
Ascletis Pharma, Inc.
HK$12.33
HK$13.14B
-47.65
235.31%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$16.21B
-54.55
89.15%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$9.19B
-15.58
53.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$18.65B
122.12
459.09%
―
Performance Comparison
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
26.10
2.93
12.65%
HK:1672
Ascletis Pharma, Inc.
13.58
9.57
238.65%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.87
1.98
68.51%
HK:2162
Keymed Biosciences, Inc.
55.80
26.65
91.42%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.49
5.41
53.67%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
44.00
36.09
456.26%